verint systems - VRNT
VRNT
Close Chg Chg %
15.96 0.03 0.19%
Closed Market
15.99
+0.03 (0.19%)
Volume: 814.93K
Last Updated:
Apr 17, 2025, 4:00 PM EDT
Company Overview: verint systems - VRNT
VRNT Key Data
| Open $15.99 | Day Range 15.91 - 16.20 |
| 52 Week Range 14.15 - 38.11 | Market Cap $993.59M |
| Shares Outstanding 62.14M | Public Float 61.04M |
| Beta 1.32 | Rev. Per Employee N/A |
| P/E Ratio 15.44 | EPS $1.04 |
| Yield 0.00% | Dividend $38.00 |
| EX-DIVIDEND DATE Feb 2, 2021 | SHORT INTEREST N/A |
| AVERAGE VOLUME 1.21M |
VRNT Performance
| 1 Week | 0.69% | ||
| 1 Month | -25.28% | ||
| 3 Months | -34.55% | ||
| 1 Year | -45.13% | ||
| 5 Years | -62.95% |
VRNT Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
7
Full Ratings ➔
About verint systems - VRNT
Verint Systems, Inc. engages in providing actionable intelligence. It operates through the following segments: Customer Engagement Solutions and Cyber Intelligence Solutions. The Customer Engagement segment includes customer-centric organizations optimize customer engagement, increase customer loyalty, and maximize revenue opportunities, while generating operational efficiencies, reducing cost, and mitigating risk. The Cyber Intelligence Solutions segment addresses the security intelligence market. The company was founded by Daniel Bodner in February 1994 and is headquartered in Melville, NY.
VRNT At a Glance
Verint Systems, Inc.
225 Broadhollow Road
Melville, New York 11747
| Phone | 1-800-483-7468 | Revenue | 909.19M | |
| Industry | Information Technology Services | Net Income | 82.27M | |
| Sector | Technology Services | Employees | 3,800 | |
| Fiscal Year-end | 01 / 2026 | |||
| View SEC Filings |
VRNT Valuation
| P/E Current | 15.44 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 24.508 |
| Price to Sales Ratio | 1.752 |
| Price to Book Ratio | 1.778 |
| Price to Cash Flow Ratio | 10.116 |
| Enterprise Value to EBITDA | 12.724 |
| Enterprise Value to Sales | 2.49 |
| Total Debt to Enterprise Value | 0.198 |
VRNT Efficiency
| Revenue/Employee | 239,259.474 |
| Income Per Employee | 21,649.211 |
| Receivables Turnover | 3.085 |
| Total Asset Turnover | 0.403 |
VRNT Liquidity
| Current Ratio | 1.10 |
| Quick Ratio | 1.073 |
| Cash Ratio | 0.418 |
VRNT Profitability
| Gross Margin | 70.144 |
| Operating Margin | 14.12 |
| Pretax Margin | 10.817 |
| Net Margin | 9.048 |
| Return on Assets | 3.643 |
| Return on Equity | 6.354 |
| Return on Total Capital | 4.641 |
| Return on Invested Capital | 4.873 |
VRNT Capital Structure
| Total Debt to Total Equity | 33.957 |
| Total Debt to Total Capital | 25.349 |
| Total Debt to Total Assets | 19.62 |
| Long-Term Debt to Equity | 38.625 |
| Long-Term Debt to Total Capital | 19.326 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Verint Systems - VRNT
Collapse All in section
| All values USD millions. | 2022 | 2023 | 2024 | 2025 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 874.51M | 902.25M | 910.39M | 909.19M | |
Sales Growth
| -31.34% | +3.17% | +0.90% | -0.13% | |
Cost of Goods Sold (COGS) incl D&A
| 327.59M | 321.25M | 296.19M | 271.45M | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 75.45M | 67.96M | 74.48M | 49.53M | |
Depreciation
| 24.43M | 22.12M | 31.18M | 18.33M | |
Amortization of Intangibles
| 51.02M | 45.84M | 40.30M | 28.80M | |
COGS Growth
| -26.24% | -1.94% | -7.80% | -8.35% | |
Gross Income
| 546.92M | 581.00M | 614.20M | 637.74M | |
Gross Income Growth
| -34.07% | +6.23% | +5.71% | +3.83% | |
Gross Profit Margin
| +62.54% | +64.39% | +67.47% | +70.14% |
| 2022 | 2023 | 2024 | 2025 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 495.26M | 521.78M | 478.44M | 509.36M | |
Research & Development
| 123.43M | 130.25M | 131.35M | 143.48M | |
Other SG&A
| 371.83M | 391.53M | 347.08M | 365.88M | |
SGA Growth
| -31.16% | +5.36% | -8.31% | +6.46% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| 6.97M | 792.00K | 56.42M | 21.98M | |
EBIT after Unusual Expense
| 44.69M | 58.42M | 79.35M | 106.40M | |
Non Operating Income/Expense
| 4.13M | 4.21M | (7.74M) | 2.08M | |
Non-Operating Interest Income
| 233.00K | 3.30M | 6.94M | 6.60M | |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 9.31M | 7.88M | 10.33M | 10.13M | |
Interest Expense Growth
| -73.85% | -15.40% | +31.19% | -1.95% | |
Gross Interest Expense
| 9.31M | 7.88M | 10.33M | 10.13M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 39.50M | 54.76M | 61.27M | 98.35M | |
Pretax Income Growth
| +143.51% | +38.62% | +11.89% | +60.51% | |
Pretax Margin
| +4.52% | +6.07% | +6.73% | +10.82% | |
Income Tax
| 23.85M | 39.10M | 21.64M | 15.25M | |
Income Tax - Current - Domestic
| 4.34M | 33.37M | 22.91M | 931.00K | |
Income Tax - Current - Foreign
| 30.84M | 15.28M | 16.36M | 18.26M | |
Income Tax - Deferred - Domestic
| 6.97M | (8.71M) | (17.22M) | (1.58M) | |
Income Tax - Deferred - Foreign
| (18.29M) | (835.00K) | (420.00K) | (2.36M) | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 15.65M | 15.66M | 39.63M | 83.10M | |
Minority Interest Expense
| 1.24M | 761.00K | 1.02M | 832.00K | |
Net Income
| 14.41M | 14.90M | 38.61M | 82.27M | |
Net Income Growth
| +298.33% | +3.37% | +159.16% | +113.07% | |
Net Margin Growth
| +1.65% | +1.65% | +4.24% | +9.05% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 14.41M | 14.90M | 38.61M | 82.27M | |
Preferred Dividends
| 18.92M | 20.80M | 20.80M | 17.28M | |
Net Income Available to Common
| (4.51M) | (5.90M) | 17.81M | 64.99M | |
EPS (Basic)
| -0.0687 | -0.0903 | 0.2783 | 1.0457 | |
EPS (Basic) Growth
| +70.00% | -31.44% | +408.19% | +275.75% | |
Basic Shares Outstanding
| 65.59M | 65.33M | 63.99M | 62.15M | |
EPS (Diluted)
| -0.0687 | -0.0903 | 0.2769 | 1.0356 | |
EPS (Diluted) Growth
| +70.00% | -31.44% | +406.64% | +274.00% | |
Diluted Shares Outstanding
| 65.59M | 65.33M | 64.32M | 62.76M | |
EBITDA
| 127.11M | 127.18M | 210.25M | 177.91M | |
EBITDA Growth
| -38.38% | +0.06% | +65.32% | -15.38% | |
EBITDA Margin
| +14.53% | +14.10% | +23.09% | +19.57% |
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 36.00 | |
| Number of Ratings | 7 | Current Quarters Estimate | 0.382 | |
| FY Report Date | 04 / 2025 | Current Year's Estimate | 2.945 | |
| Last Quarter’s Earnings | 0.99 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 2.62 | Next Fiscal Year Estimate | 3.19 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 7 | 7 | 7 | 6 |
| Mean Estimate | 0.38 | 0.63 | 2.95 | 3.19 |
| High Estimates | 0.64 | 0.74 | 3.07 | 3.28 |
| Low Estimate | 0.13 | 0.57 | 2.89 | 3.12 |
| Coefficient of Variance | 50.59 | 8.68 | 1.88 | 1.75 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 4 | 4 | 4 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 3 | 3 | 3 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Verint Systems - VRNT
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Verint Systems - VRNT
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Apr 15, 2025 | Linda Marie Crawford Director | 18,553 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 15, 2025 | Richard N. Nottenburg Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 15, 2025 | Richard N. Nottenburg Director | 6,859 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 15, 2025 | Richard N. Nottenburg Director | 6,859 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 15, 2025 | William H. Kurtz Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 15, 2025 | William H. Kurtz Director | 6,859 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 15, 2025 | William H. Kurtz Director | 20,193 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 15, 2025 | Andrew D. Miller Director | 26,895 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 15, 2025 | Kristen O. Robinson Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 15, 2025 | Kristen O. Robinson Director | 6,859 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 15, 2025 | Kristen O. Robinson Director | 15,739 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 15, 2025 | R. Reid French Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 15, 2025 | R. Reid French Director | 6,859 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 15, 2025 | R. Reid French Director | 23,253 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 15, 2025 | Stephen J. Gold Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 15, 2025 | Stephen J. Gold Director | 6,859 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 15, 2025 | Stephen J. Gold Director | 28,473 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $16.07 per share | 457,561.11 |
| Apr 15, 2025 | Stephen J. Gold Director | 31,217 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 15, 2025 | Andrew D. Miller Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 15, 2025 | Andrew D. Miller Director | 6,859 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |